Arax Advisory Partners’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Arax Advisory Partners’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$584K	Buy	4,929 +4,482	+1,003%	+$485K	﹤0.01%	1546
2026 Q1	$46.4K	Buy	+447	New	+$47.2K	﹤0.01%	1721
2022 Q2	–	Sell	-20	Closed	-$2K	–	1215
2022 Q1	$2K	Buy	+20	New	+$1.55K	﹤0.01%	957

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Arax Advisory Partners's PJP Position: Q2 2026 in Review

Arax Advisory Partners increased its Invesco Pharmaceuticals ETF (PJP) stake by 1,003% in Q2 2026, buying an estimated $485K and bringing the position to 4,929 shares worth $584K. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

Arax Advisory Partners first reported a position in PJP in Q1 2022 and has held it in 3 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Arax Advisory Partners held 4,929 shares of Invesco Pharmaceuticals ETF worth $584K as of Q2 2026.
Arax Advisory Partners bought 4,482 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $485K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1546 holding.
Arax Advisory Partners first reported a position in Invesco Pharmaceuticals ETF in Q1 2022 and has held it in 3 quarters since.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.